Geode Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.1M Buy
3,650,688
+244,862
+7% +$1.14M ﹤0.01% 2039
2025
Q1
$18.7M Buy
3,405,826
+54,400
+2% +$299K ﹤0.01% 1938
2024
Q4
$11.4M Buy
3,351,426
+17,956
+0.5% +$60.9K ﹤0.01% 2293
2024
Q3
$9.5M Buy
3,333,470
+93,091
+3% +$265K ﹤0.01% 2415
2024
Q2
$7.29M Buy
3,240,379
+195,015
+6% +$439K ﹤0.01% 2515
2024
Q1
$6.73M Buy
3,045,364
+153,287
+5% +$339K ﹤0.01% 2544
2023
Q4
$6.8M Buy
2,892,077
+118,784
+4% +$279K ﹤0.01% 2542
2023
Q3
$5.16M Buy
2,773,293
+91,488
+3% +$170K ﹤0.01% 2621
2023
Q2
$7.03M Buy
2,681,805
+151,100
+6% +$396K ﹤0.01% 2506
2023
Q1
$4.13M Buy
2,530,705
+97,994
+4% +$160K ﹤0.01% 2721
2022
Q4
$3.24M Buy
2,432,711
+79,689
+3% +$106K ﹤0.01% 2870
2022
Q3
$3.67M Buy
2,353,022
+179,468
+8% +$280K ﹤0.01% 2833
2022
Q2
$3.35M Buy
2,173,554
+1,011,664
+87% +$1.56M ﹤0.01% 2924
2022
Q1
$2.97M Buy
1,161,890
+156,890
+16% +$402K ﹤0.01% 3058
2021
Q4
$2.94M Buy
1,005,000
+300,830
+43% +$881K ﹤0.01% 3174
2021
Q3
$1.73M Buy
704,170
+131,207
+23% +$321K ﹤0.01% 3426
2021
Q2
$2.33M Sell
572,963
-212,738
-27% -$865K ﹤0.01% 3220
2021
Q1
$3.54M Buy
785,701
+66,697
+9% +$301K ﹤0.01% 2950
2020
Q4
$3.54M Buy
719,004
+108,800
+18% +$535K ﹤0.01% 2781
2020
Q3
$3.62M Buy
610,204
+125,118
+26% +$742K ﹤0.01% 2575
2020
Q2
$1.29M Sell
485,086
-3,850
-0.8% -$10.2K ﹤0.01% 3061
2020
Q1
$953K Buy
488,936
+134,474
+38% +$262K ﹤0.01% 3041
2019
Q4
$2.5M Buy
354,462
+15,952
+5% +$112K ﹤0.01% 2875
2019
Q3
$3.33M Buy
338,510
+14,834
+5% +$146K ﹤0.01% 2623
2019
Q2
$3.7M Buy
323,676
+53,794
+20% +$615K ﹤0.01% 2583
2019
Q1
$2.71M Buy
269,882
+187,190
+226% +$1.88M ﹤0.01% 2677
2018
Q4
$1.41M Buy
82,692
+15,459
+23% +$263K ﹤0.01% 2952
2018
Q3
$1.18M Buy
+67,233
New +$1.18M ﹤0.01% 3149